Contact:Peter DeNardoDirector, Investor Relations and Corporate CommunicationsAmyris, Inc. +1 (510) 740-7481 firstname.lastname@example.org email@example.com
EMERYVILLE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it is rescheduling the release of its financial results for the third quarter ended September 30, 2017 to after market close on Tuesday, November 14, 2017. Amyris is rescheduling its earnings call to November 14 to provide time to complete, and assess the impact of, an in-process commercial agreement. Amyris has no current plans for new financings or debt offerings. The company will hold its quarterly conference call to discuss these results, as well as provide an update on the company's business and outlook, at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, November 14, 2017. Conference Call: Tuesday, November 14, 2017, 4:30 p.m. ET/1:30 p.m. PT Dial-in Number: (866) 516-3867 (U.S. & International)Access Code: 9293849 Audio Webcast: A live webcast of the call will be available online on the Amyris website. To listen via live webcast, please visit: http://investors.amyris.com. A replay of the webcast will be available on the Investor Relations section of the company's website approximately two hours after the conclusion of the call. About Amyris Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com. Forward-Looking Statements This release contains forward-looking statements, and any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as a potential commercial agreement and its impact and expectations regarding future financing activity), that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to Amyris's liquidity and ability to fund operating and capital expenses, uncertainty regarding consummating proposed transactions, including the timing thereof, risks related to Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on August 14, 2017. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise. Amyris, the Amyris logo and No Compromise are registered trademarks of Amyris, Inc.